The pathology of malabsorption: Current concepts

Histopathology

Volumn 50, Issue 1, 2007, Pages 64-82

  Owens, S R ^b   Greenson, J K ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Autoimmune enteropathy; Bacterial overgrowth; Coeliac disease; Giardiasis; Gluten sensitive enteropathy; Malabsorption; Sprue; Whipple's disease

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACRODERMATITIS ENTEROPATHICA; BACTERIAL OVERGROWTH; CELIAC DISEASE; CRYPTOSPORIDIOSIS; DIGESTIVE SYSTEM FUNCTION DISORDER; ENTEROCYTOZOON; ENTEROPATHY; ENVIRONMENTAL FACTOR; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INTESTINE LIPODYSTROPHY; INTESTINE LYMPHANGIECTASIA; MALABSORPTION; MICROSPORIDIOSIS; MUCOSAL DISEASE; PATHOLOGY; PRIORITY JOURNAL; REVIEW; TROPICAL SPRUE; VIRUS INFECTION;

HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MALABSORPTION SYNDROMES;

BACTERIA (MICROORGANISMS);

EID: 33845607661     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2006.02547.x     Document Type: Review

References (215)

1. Johnson LR. Gastrointestinal physiology. Philadelphia: Mosby 2001.
2. Brasitus TA, Sitrin MD. Intestinal malabsorption syndromes. Annu. Rev. Med. 1990; 41; 339-347.
3. Griffiths A, Taylor RH. Postgastrectomy pancreatic malabsorption: is there a case for intervention? Eur. J. Gastroenterol. Hepatol. 1999; 11; 231-237.
4. Maes BD, Hiele MI, Geypens BJ, Ghoos YF, Rutgeerts PJ. Gastric emptying of the liquid, solid and oil phase of a meal in normal volunteers and patients with Billroth II gastrojejunostomy. Eur. J. Clin. Invest. 1998; 28; 197-204.
5. Bae JM, Park JW, Yang HK, Kim JP. Nutritional status of gastric cancer patients after total gastrectomy. World J. Surg. 1999; 23; 983-984.
6. Friess H, Bohm J, Muller MW et al. Maldigestion after total gastrectomy is associated with pancreatic insufficiency. Am. J. Gastroenterol. 1996; 91; 341-347.
7. Meyer JH. Nutritional outcomes of gastric operations. Gastroenterol. Clin. North Am. 1994; 23; 227-260.
8. Kreckler S, Dowson H, Willson P. Dumping syndrome as a complication of laparoscopic Nissen fundoplication in an adult. JSLS 2006; 10; 94-96.
9. Abell TL, Minocha A. Gastrointestinal complications of bariatric surgery: diagnosis and therapy. Am. J. Med. Sci. 2006; 331; 214-218.
10. Connor F. Gastrointestinal complications of fundoplication. Curr. Gastroenterol. Report 2005; 7; 219-226.
11. Gilger MA, Yeh C, Chiang J, Dietrich C, Brandt ML, El-Seraq HB. Outcomes of surgical fundoplication in children. Clin. Gastroenterol. Hepatol. 2004; 2; 978-984.
12. Ukleja A. Dumping syndrome: pathophysiology and treatment. Nutr. Clin. Pract. 2005; 20; 517-525.
13. Bouras EP, Scolapio JS. Gastric motility disorders: management that optimizes nutritional status. J. Clin. Gastroenterol. 2004; 38; 549-557.
14. Saito A, Noguchi Y, Yoshikawa T et al. Gastrectomized patients are in a state of chronic protein malnutrition: analyses of 23 amino acids. Hepatogastroenterology 2001; 48; 585-589.
15. Wenig BM, Heffess CS. Inflammatory, infectious, and other nonneoplastic disorders of the pancreas. In Odze RD, Goldblum JR, Crawford JM eds. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. Philidelphia: Saunders 2004; 673-697.
16. Lankisch PG. Enzyme treatment of exocrine pancreatic insufficiency in chronic pancreatitis. Digestion 1993; 54 (Suppl. 2); 21-29.
17. Bruno MJ, Haverkort EB, Tytgat GN, van Leeuwen DJ. Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment. Am. J. Gastroenterol. 1995; 90; 1383-1393.
18. Dimagno MJ, Dimagno EP. Chronic pancreatitis. Curr. Opin. Gastroenterol. 2006; 22; 487-497.
19. Littlewood JM, Wolfe SP, Conway SP. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis. Pediatr. Pulmonol. 2006; 41; 35-49.
20. Bayless TM, Christopher NL. Disaccharidase deficiency. Am. J. Clin. Nutr. 1969; 22; 181-190.
21. Montalto M, Curigliano V, Santoro L et al. Management and treatment of lactose malabsorption. World J. Gastroenterol. 2006; 12; 187-191.
22. Troelsen JT. Adult-type hypolactasia and regulation of lactase expression. Biochim. Biophys. Acta 2005; 1723; 19-32.
23. Auricchio S. Genetically determeined disaccharidase deficiencies. In Walker WA, Durie PR, Hamilton JR et al. eds Pediatric gastrointestinal disease. Philadelphia and Toronto: Decker 1991; 647.
24. Wang Y, Harvey CB, Hollox EJ et al. The genetically programmed down-regulation of lactase in children. Gastroenterology 1998; 114; 1230-1236.
25. Robayo-Torres CC, Quezada-Calvillo R, Nichols BL. Disaccharide digestion: clinical and molecular aspects. Clin. Gastroenterol. Hepatol. 2006; 4; 276-287.
26. Maiuri L, Rossi M, Raia V, Paparo F, Garipoli V, Aurrichio S. Surface staining on the villus of lactase protein and lactase activity in adult-type hypolactasia. Gastroenterology 1993; 105; 708-714.
27. Day DW, Jass JR, Price AB et al. Morson and Dawson's gastrointestinal pathology. Malden, MA: Blackwell 2003.
28. Farrell RJ, Kelly CP. Celiac sprue. N. Engl. J. Med. 2002; 346; 180-188.
29. Chand N, Anastasios AM. Celiac disease: current concepts in diagnosis and treatment. J. Clin. Gastroenterol. 2006; 40; 3-14.
30. Holdstock G, Eade DE, Isaacson P, Smith CL. Endoscopic duodenal biopsy in celiac disease and duodenitis. Scand. J. Gastroenterol. 1979; 14; 717-720.
31. Collin P. New diagnostic findings in celiac disease. Ann. Med. 1999; 31; 399-405.
32. Antonioli DA. Celiac disease: a progress report. Mod. Pathol. 2003; 16; 342-346.
33. Baer AX, Bayless TM, Yardley JH. Intestinal ulceration and malabsorption syndromes. Gastroenterology 1980; 79;754-765.
34. Catassi C, Fabiani E. The spectrum of celiac disease in children. Baillieres Clin. Gastroenterol. 1997; 11; 485-507.
35. Corazza GR, Gasbarrini G. Coeliac disease in adults. Baillieres Clin. Gastroenterol. 1995; 9; 329-350.
36. Green PHR. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology 2005; 128; S74-S78.
37. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001; 120; 636-651.
38. Farstad IN, Johansen F-E, Vlatkovic L et al. Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression. Gut 2002; 51; 372-378.
39. Mahadeva S, Wyatt JI, Howdle PD. Is a raised intraepithelial lymphocyte count with normal duodenal villous architecture clinically relevant? J. Clin. Pathol. 2002; 55; 424-428.
40. Goldstein NS. Proximal small-bowel mucosal villous intraepithelial lymphocytes. Histopathology 2004; 44; 199-205.
41. Chang F, Mahadeva U, Deere H. Pathological and clinical significance of increased intraepithelial lymphocytes (IELs) in small bowel mucosa. APMIS 2005; 113; 385-399.
42. Kakar S, Nehra V, Murray JA, Dayharsh GA, Burgart LJ. Significance of intraepithelial lymphocytosis in small bowel biopsy samples with normal mucosal architecture. Am. J. Gastroenterol. 2003; 98; 2027-2033.
43. Rubin CE, Brandborg LL, Phelps PC, Taylor HC Jr. Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue. Gastroenterology 1968; 54 (Suppl.); 800-802.
44. Oberhuber G. Histopathology of celiac disease. Biomed. Pharmacother. 2000; 54; 368-372.
45. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992; 102; 330-354.
46. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of celiac disease: time for a standardized report scheme for pathologists. Eur. J. Gastroenterol. Hepatol. 1999; 11; 1185-1194.
47. Ravelli A, Bolognini S, Gambarotti M, Villanacci V. Variability of histologic lesions in relation to biopsy site in glutensensitive enteropathy. Am. J. Gastroenterol. 2005; 100; 177-185.
48. Oberhuber G, Bodingbauer M, Mosberger I, Stolte M, Vogelsang H. High proportion of granzyme B-positive (activated) intraepithelial and lamina propria lymphocytes in lymphocytic gastritis. Am. J. Surg. Pathol. 1998; 22; 450-458.
49. Cellier C, Patey N, Mauvieux L et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gatroenterology 1998; 114; 471-481.
50. Vogelsang H, Oberhuber G, Wyatt J. Lymphocytic gastritis and gastric permeability in patients with celiac disease. Gastroenterology 1996; 111; 73-77.
51. Brown I, Mino-Kenudson M, Deshpande V, Lauwers GY. Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis. Arch. Pathol. Lab. Med. 2006; 130; 1020-1025.
52. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000; 119; 234-242.
53. Schuppan D, Dennis MD, Kelly CP. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management. Nutr. Clin. Care 2005; 8; 54-69.
54. Dieterich W, Laag E, Schopper H et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998; 115; 1317-1321.
55. Sulkanen S, Halttunen T, Laurila K et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115; 1322-1328.
56. Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A. Coeliac disease-associated disorders and survival. Gut 1994; 35; 1215-1218.
57. Falchuk ZM, Gebhard RL, Sessoms C, Strober W. An in vitro model of gluten-sensitive enteropathy. Effect of gliadin on intestinal epithelial cells of patients with gluten-sensitive enteropathy in organ culture. J. Clin. Invest. 1974; 53; 487-500.
58. Katz AJ, Falchuk ZM. Definitive diagnosis of gluten-sensitive enteropathy: use of an in vitro organ culture model. Gastroenterology 1978; 75; 695-700.
59. Samloff IM, David JS, Schenk EA. A clinical and histochemical study of gluten-free diet. Gastroenterology 1965; 48; 155-172.
60. Yardley JH, Bayless TM, Norton JH et al. Celiac disease: a study of the jejunal epithelium before and after a gluten-free diet. N. Engl. J. Med. 1962; 267; 1173-1179.
61. Lancaster-Smith M, Packer S, Kumar PJ, Harries JT. Cellular infiltrate of the jejunum after re-introduction of dietary gluten in children with treated celiac disease. J. Clin. Pathol. 1976; 29; 587-591.
62. Sollid LM, Lie BA. Celiac disease genetics: current concepts and practical applications. Clin. Gastroenterol. Hepatol. 1999; 11; 1185-1194.
63. MacDonald WC, Dobbins WO 3rd, Rubin CE. Studies of the familial nature of celiac sprue using biopsy of the small intestine. N. Engl. J. Med. 1965; 272; 448-456.
64. Hogberg L, Falth-Magnusson K, Grodzinsky E, Stenhammar L. Familial prevalence of celiac disease: a twenty-year follow-up study. Scand. J. Gastroenterol. 2003; 1; 61-65.
65. Stenhammar L, Brandt A, Wagermark J. A family study of celiac disease. Acta Paediatr. Scand. 1982; 71; 625-628.
66. Molberg O, Mcadam SN, Korner R. et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat. Med. 1998; 4; 713-717.
67. Lawler M, Humphries P, O'Farrelly C et al. Adenovirus E1A gene detection by polymerase chain reaction in both the normal and celiac duodenum. Gut 1994; 35; 1226-1232.
68. Weinstein WM, Saunders DR, Tytgat GN et al. Collagenous sprue - an unrecognized type of malabsorption. N. Engl. J. Med. 1970; 283; 1297-1301.
69. Daum S, Cellier C, Mulder CJJ. Refractory celiac disease. Best Prac. Res. Clin. Gastroenterol. 2005; 19; 413-424.
70. Ryan BM, Kelleher D. Refractory celiac disease. Gastroenterology 2000; 119; 243-251.
71. Catassi C, Ratsch I-M, Fabian E et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet 1994; 343; 200-203.
72. Swinson CM, Slavin G, Coles EC, Booth CC. Coeliac disease and malignancy. Lancet 1983; 1; 111-115.
73. Catassi C, Bearzi I, Holmes GKT. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 2005; 128; S79-S86.
74. Smedby KE, Akerman M, Hildebrand H, Glimelius B, Ekbom A, Askling J. Malignant lymphomas in celiac disease: evidence of increased risks for lymphoma types other than enteropathytype T cell lymphoma. Gut 2005; 54; 54-59.
75. Cellier C, Delabesse E, Helmer C et al. Refractory sprue, celiac dieases, and enteropathy-associated T-cell lymphoma. Lancet 2000; 356; 203-208.
76. Gebhard RL, Falchuk ZH, Katz SL, Sessoms C, Rogentine GN, Strober W. Dermatitis herpetiformis. Immunological concomitants of small intestinal diseases and the relationship to histocompatibility antigens. J. Clin. Invest. 1974; 54; 98-103.
77. Weinstein WM. Latent celiac sprue. Gastroenterology 1974; 66; 489.
78. Unsworth DJ, Leonard NL, Fry L. Antireticulin and antigliadin antibodies in dermatitis herpetiformis and celiac disease. In Beutner EH, Chorzelski TC, Kumar V eds, Chapter 25. Immunopathology of the skin, 3rd edn. New York: John Wiley & Sons Inc. 1987.
79. Marks J, Birkell D, Shuster S, Roberts DF. Small intestinal mucosal abnormalities in relatives of patients with dermatitis herpetiformis. Gut 1970; 11; 493-497.
80. Scott BB, Young S, Rajals SM, Marks J, Losowsky MS. Coeliac disease and dermatitis herpetiformis: further studies on their relatonship. Gut 1976; 17; 759-762.
81. Loft DE, Nwokolo CU, Ciclitira PJ. The diagnosis of gluten sensitivity and celiac disease - the two are not mutually inclusive. Eur. J. Gastroenterol. Hepatol. 1998; 10; 911-913.
82. Baker SJ, Mathan VI. Syndrome of tropical sprue in India. Am. J. Clin. Nutr. 1968; 21; 984-993.
83. Schenk EA, Samloff IM, Klipstein FA. Morphologic characteristics of jejunal biopsy in celiac disease and tropical sprue. Am. J. Pathol. 1965; 47; 765-781.
84. Swanson VL, Thomassen RW. Pathology of the jejunal mucosa in tropical sprue. Am. J. Pathol. 1965; 46; 511-551.
85. Wheby MS, Swanson VL, Bayless TM. Comparison of the ileal and jejunal biopsies in tropical sprue. Am. J. Clin. Nutr. 1971; 24; 117-123.
86. Robert ME. Inflammatory disorders of the small intestine. In Odze RD, Goldblum JR, Crawford JM eds. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. Philidelphia: Saunders 2004; 177-212.
87. Cook GC. Aetiology and pathogenesis of postinfective tropical malabsorption (tropical sprue). Lancet 1984; 1; 721-723.
88. Cook GC. Postinfective malabsorption (includes tropical sprue). In Bouchier AD, Alan RN, Hodgson JF, Deighley MRB eds. Gastroenterology. Clinical practice and science. Philadelphia: Saunders 1993; 522-537.
89. Walker MM. What is tropical sprue? J. Gastroenterol. Hepatol. 2003; 18; 887-890.
90. Ghoshal UC, Ghoshal U, Ayyagari A et al. Tropical sprue is associated with contamination of small bowel with aerobic bacteria and reversible prolongation of orocecal transit time. J. Gastroenterol. Hepatol. 2003; 18; 540-547.
91. Cook GC. 'Tropical sprue': some early investigators favoured an infective cause, but was a coccidian protozoan involved? Gut 1996; 39; 428-429.
92. Daum S, Sahi E, Jansen A et al. Adult autoimmune enteropathy treated successfully with tacrolimus. Digestion 2003; 68; 86-90.
93. Leon F, Olivencia P, Rodriguez-Pena R et al. Clinical and immunological features of adult-onset generalized autoimmune gut disorder. Am. J. Gastroenterol. 2005; 99; 1563-1571.
94. Russo PA, Brochu P, Seidman EG, Roy CC. Autoimmune enteropathy. Pediatr. Dev. Pathol. 1999; 2; 65-71.
95. Bacchetta R., Passerini L, Gambineri E et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 2006; 116; 1713-1722.
96. Le Bras S, Geha RS. IPEX and the role of FOXP3 in the developtment and function of human Tregs. J. Clin. Invest. 2006; 116; 1473-1475.
97. Ruemmele FM, Brousse N, Goulet O. Autoimmune enteropathy: molecular concepts. Curr. Opin. Gastroenterol. 2004; 20; 587-591.
98. Moore L, Xu X, Davidson G et al. Autoimmune enteropathy with anti-goblet cell antibodies. Hum. Pathol. 1995; 26; 1162-1168.
99. Hori K, Fukuda Y, Tomita T et al. Intestinal goblet cell autoantibody associated enteropathy. J. Clin. Pathol. 2003; 56; 629-630.
100. Waldmann TA, Steinfeld JL, Dutcher TF et al. The role of the gastrointestinal system in 'idiopathic hypoproteinemia. Gastroenterology 1961; 41; 197-207.
101. Waldmann TA. Protein-losing enteropathy. Gastroenterology 1966; 50; 422-443.
102. Abramowsky C, Hupertz V, Kilbridge P et al. Intestinal lymphangiectasia in children: a study of upper gastrointestinal endoscopic biopsies. Pediatr. Pathol. 1989; 9; 289-297.
103. Van Tilburg AJ, van Blankenstein M, Verschoor L. Intestinal lymphangiectasia in systemic sclerosis. Am. J. Gastroenterol. 1988; 83; 1417-1419.
104. Mak K-L, Hui P-K, Chan W-Y et al. Mucosal lymphangiectasia in gastric adenocarcinoma. Arch. Pathol. Lab. Med. 1996; 120; 78-80.
105. Heresback D, Raoul J-L, Genetet N et al. Immunological study in primary intestinal lymphangiectasia. Digestion 1994; 55; 59-64.
106. Fuss IJ, Strober W, Cuccherini BA et al. Intestinal lymphangiectasia, a disease characterized by selective loss of naïve CD45RA lymphocytes into the gastrointestinal tract. Eur. J. Immunol. 1998; 28; 4275-4285.
107. Aoyagi K, Iida M, Yao T et al. Characteristic endoscopic features of intestinal lymphangiectasia: correlation with histological findings. Hepatogastroenterology 1997; 44; 133-138.
108. Riemann JF, Schmidt H. Synopsis of endoscopic and other morphological findings in intestinal lymphangiectasia. Endoscopy 1981; 13; 60-63.
109. Persic M, Browse NL, Prpic I. Intestinal lymphangiectasia and protein losing enteropathy responding to small bowel resection. Arch. Dis. Child. 1998; 78; 194-196.
110. Mitomi H, Atari E, Uesugi H et al. Distinctive diffuse duodenitis associated with ulcerative colitis. Dig. Dis. Sci. 1997; 42; 684-693.
111. Valdez R, Appelman HD, Bronner MP, Greenson JK. Diffuse duodenitis associated with ulcerative colitis. Am. J. Surg. Pathol. 2000; 24; 1407-1413.
112. Sasaki M, Okada K, Koyama S et al. Ulcerative colitis complicated by gastroduodenal lesions. J. Gastroenterol. 1996; 31; 585-589.
113. Sjogren RW. Gastrointestinal features of scleroderma. Curr. Opin. Rheumatol. 1996; 8; 569-575.
114. Young MA, Rose S, Reynolds JC. Gastrointestinal manifestations of scleroderma. Rheum. Dis. Clin. North Am. 1996; 22; 797-823.
115. Sjogren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum. 1994; 37; 1265-1282.
116. Ament ME, Shimoda SS, Saunders DP, Rubin CE. Pathogenesis of steatorrhea in three cases of small intestinal stasis syndrome. Gastroenterology 1972; 63; 728-747.
117. Gianella RA, Rout WR, Toskes PP. Jejunal brush border injury and impaired sugar and amino acid uptake in the blind-loop syndrome. Gastroenterology 1974; 67; 965-974.
118. Goldstein F. Mechanisms of malabsorption and malnutrition in the blind-loop syndrome. Gastroenterology 1971; 61; 780-784.
119. Kaye SA, Lim SG, Taylor M, Patel S, Gillespie S, Black CM. Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Br. J. Rheumatol. 1995; 34; 265-269.
120. Krishnamurthy S, Schuffler MD. Pathology of neuromuscular disorders of the small intestine and colon. Gastroenterology 1987; 93; 610-639.
121. Schuffler MD, Beegle RG. Progressive systemic sclerosis of the gastrointestinal tract and hereditary hollow visceral myopathy: two distinguishable disorders of intestinal smooth muscle. Gastroenterology 1979; 77; 664-671.
122. Ament ME, Ochs HD, Davis SD. Structure and function of the gastrointestinal tract in primary immunodeficiency syndromes: a study of 39 patients. Medicine 1973; 52; 227-248.
123. Ament ME. Immunodeficiency syndromes and the gut. Scand. J. Gastroenterol. Suppl. 1985; 114; 127-135.
124. Ament ME, Rubin CE. Relation of giardiasis to abnormal intestinal structure and function in gastrointestinal immunodeficiency syndromes. Gastroenterology 1972; 62; 216-226.
125. Kagnoff MF. Immunology and inflammation of the gastrointestinal tract. In Sleisinger MH, Fordtran JS eds. Gastrointestinal disease, 5th edn. Philadelphia: Saunders 1993; 45-86.
126. Nagura H, Kohler PF, Brown WR. Immunocytochemical characterization of the lymphocytes in nodular lymphoid hyperplasia of the bowel. Lab. Invest 1979; 40; 66-73.
127. Tytgat GN, Huibregtse K, Schellekens PTA, Feltkamp-Vroom TH. Clinical and immunologic observations in a patient with late onset immunodeficiency. Gastroenterology 1979; 76; 1458-1465.
128. Yardley JH, Hendrix TR. Immunologic status in patients with giardiasis. Gastroenterology 1980; 78; 421-422.
129. Cunningham-Rundles C. Clinical and immunologic analysis of 103 patients with common variable immunodeficiency. J. Clin. Immunol. 1989; 9; 22-33.
130. Gillin JS, Shike M, Alcock N et al. Malabsorption and mucosal abnormalities of the small intestine in the acquired immunodeficiency syndrome. Ann. Intern. Med. 1985; 102; 619-622.
131. Kotler D, Gaetz H, Lange M, Klein EB, Holt PR. Enteropathy associated with the acquired immunodeficiency syndrome. Ann. Intern. Med. 1984; 101; 421-428.
132. Kotler DP. Human immunodeficiency virus-related wasting: malabsorption syndromes. Semin. Oncol. 1998; 25 (2 Suppl. 6); 70-75.
133. Greenson JK, Belitsos PC, Yardley JH, Bartlett JG. AIDS enteropathy: occult enteric infections and duodenal mucosal alterations in chronic diarrhea. Ann. Intern. Med. 1991; 114; 366-372.
134. Laughon BE, Druckman DA, Vernon A et al. Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology 1988; 94; 984-993.
135. Smith PD, Lane HC, Gill VJ et al. Intestinal infection in patients with the acquired immunodeficiency syndrome (AIDS): etiology and response to therapy. Ann. Intern. Med. 1988; 108; 433-438.
136. Kotler DP, Orenstein JM. Chronic diarrhea and malabsorption associated with enteropathogenic bacterial infection in a patient with AIDS. Ann. Intern. Med. 1993; 119; 127-128.
137. Eeftinck-Schattenkerk JK, van Gool T, van Ketal RJ et al. Clinical significance of small-intestinal microsporidiosis in HIV-1-infected individuals. Lancet 1991; 337; 895-898.
138. Yan Z, Nguyen S, Poles M, Melamed J, Scholes JV. Adenovirus colitis in human immunodeficiency virus infection: an underdiagnosed entity. Am. J. Surg. Pathol. 1998; 22; 1101-1106.
139. Ukarapol N, Chartapisak W, Lertprasertsuk N et al. Cytomegalovirus- associated manifestation involving the digestive tract in children with human immunodeficiency virus infection. J. Pediatr. Gastroenterol. Nutr. 2002; 35; 669-673.
140. Batman PA, Miller ARO, Forster SM, Harris JRW, Pinching AJ, Griffin GE. Jejunal enteropathy associated with human immunodeficiency virus infection: quantitiative histology. J. Clin. Pathol. 1989; 42; 275-281.
141. Cummins AG, Labrooy JT, Stanley DP, Rowland R, Shearman DJC. Quantitative histological study of enteropathy associated with HIV infection. Gut 1990; 31; 317-321.
142. Miller AR, Griffin GE, Batman P et al. Jejunal mucosal architecture and fat absorption in male homosexuals infected with human immunodeficiency virus. Q. J. Med. 1988; 69; 1009-1019.
143. Kapembwa MS, Batman PA, Fleming SC, Griffin GE. HIV enteropathy. Lancet 1989; 2; 1521-1522.
144. Batman PA, Kapembwa MS, Griffin GE. Enteropathy associated with HIV. Gut 1990; 31; 960.
145. Rotterdam H, Sommers SC. Alimentary tract biopsy lesions in the acquired immune deficiency syndrome. Pathology 1985; 17; 181-192.
146. Budhraja M, Levendoglu H, Kocka F, Mangkomkanok M, Sherer R. Duodenal mucosal T cell subpopulation and bacterial cultures in acquired immune deficiency syndrome. Am. J. Gastroenterol. 1987; 82; 427-431.
147. Ellakany S, Whiteside TL, Schade RR, van Thiel DH. Analysis of intestinal lymphocyte subpopulations in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Am. J. Clin. Pathol. 1987; 87; 356-364.
148. Rodgers VD, Fassett R, Kagnoff MF. Abnormalities in intestinal mucosal T cells in homosexual populations including those with the lymphadenopathy syndrome and acquired immunodeficiency syndrome. Gastroenterology 1986; 90; 552-558.
149. Rodgers VD, Kagnoff MF. Abnormalities of the intestinal immune system in AIDS. Gastroenterol. Clin. North Am. 1988; 17; 487-494.
150. Weber JR, Dobbins WO 3rd. The intestinal and rectal epithelial lymphocyte in AIDS: an electron-microscopic study. Am. J. Surg. Pathol. 1986; 10; 627-639.
151. Snijders F, Heenan J, van den Blink B, van Deventer SJ, ten Kate FJ. Duodenal intraepithelial and lamina propria T lymphocytes in human immunodeficiency virus-infected patients with and without diarrhoea. Scand. J. Gastroenterol. 1996; 31; 1176-1181.
152. Guadalupe M, Reay E, Sandaran S et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 2003; 77; 11709-11717.
153. Harriman GR, Smith PD, Horne MK et al. Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. Arch. Intern. Med. 1989; 149; 2039-2041.
154. Herzlich BC, Schiano TD. Reversal of apparent AIDS dementia complex following treatment with vitamin B12. J. Intern. Med. 1993; 233; 495-497.
155. Dworkin BM. Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem. Biol. Interact. 1994; 91; 181-186.
156. Ehrenpreis ED, Carlson SJ, Boorstein HL, Craig RM. Malabsorption and deficiency if vitamin B12 in HIV-infected patients with chronic diarrhea. Dig. Dis. Sci. 1994; 31; 2159-2162.
157. Taylor C, Hodgson K, Sharpstone D et al. The prevalence and severity of intestinal disaccharidase deficiency in human immunodeficiency virus-infected subjects. Scand. J. Gastroenterol. 2000; 35; 599-606.
158. Fox CH, Kotler D, Tierney A, Wilson CS, Fauci AS. Detection of HIV-1 RNA in the lamina propria of patients with AIDS and gastrointestinal disease. J. Infect. Dis. 1989; 159; 467-471.
159. Jarry A, Cortez A, Rene E, Muzeau F, Brousse N. Infected cells and immune cells in the gastrointestinal tract of AIDS patients: an immunohistochemical study of 127 cases. Histopathology 1990; 16; 133-140.
160. Modigliani R, Bodes C, Charpentier YL et al. Diarrhoea and malabsorption in acquired immune deficiency syndrome: a study of four cases with special emphasis on opportunistic protozoan infestations. Gut 1985; 26; 179-187.
161. Ullrich R, Zeitz M, Heise W, L'age M, Hoffken G, Riecken EO. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann. Intern. Med. 1989; 111; 15-21.
162. Zeitz M, Ullrich R, Schneider T, Kewenig S, Hohloch K, Riecken EO. HIV / SIV enteropathy. Ann. NY Acad. Sci. 1998; 859; 139-148.
163. Nannini EC, Okhuysen PC. HIV1 and the gut in the era of highly active antiretroviral therapy. Curr. Gastroenterol. Report 2002; 4; 392-398.
164. Quigley EMM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 2006; 130; S78-S90.
165. Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 2006; 51 (Suppl. 1); 1-22.
166. Ghoshal U, Ghoshal UC, Ranjan P, Naik SR, Ayyagary A. Spectrum and antibiotic sensitivity of bacteria contaminating the upper gut in patients with malabsorption syndrome from the tropics. BMC Gastroenterol. 2003; 3; 9.
167. Bouhnik Y, Alain S, Attar A et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am. J. Gastroenterol. 1999; 94; 1327-1331.
168. Mitsui T, Shimaoka K, Goto Y et al. Small bowel bacterial overgrowth is not seen in healthy adults but is in disabled older adults. Hepatogastroenterology 2006; 53; 82-85.
169. Teo M, Chung S, Chitti L et al. Small bowel bacterial overgrowth is a common cause of chronic diarrhea. J. Gastroenterol. Hepatol. 2004; 19; 904-909.
170. Haboubi NY, Lee GS, Montgomery RD. Duodenal mucosal morphometry of elderly patients with small intestinal bacterial overgrowth: response to antibiotic treatment. Age Ageing 1991; 20; 29-32.
171. Riordan SM, McIver CJ, Wakefield D, Duncombe VM, Thomas MC, Bolin TD. Small intestinal mucosal immunity and morphometry in luminal overgrowth of indigenous gut flora. Am. J. Gastroenterol. 2001; 96; 494-500.
172. Jonas A, Krishnan C, Forstner G. Pathogenesis of mucosal injury in the blind loop syndrome. Gastroenterology 1978; 75; 791-795.
173. Toskes PP, Giannella RA, Jervis HR, Rout WR, Takeuchi A. Small intestinal mucosal injury in the experimental blind loop syndrome. Light- and electron-microscopic and histochemical studies. Gastroenterology 1975; 68; 1193-1203.
174. Mathias JR, Clench MH. Review: pathophysiology of diarrhea caused by bacterial overgrowth of the small intestine. Am. J. Med. Sci. 1985; 289; 243-248.
175. Riordan SM, McIver CJ, Wakefield D, Duncombe VM, Bolin TD, Thomas MC. Luminal antigliadin antibodies in small intestinal bacterial overgrowth. Am. J. Gastroenterol. 1997; 92; 1335-1338.
176. Whipple GH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull. Johns Hopkins Hosp. 1907; 18; 382-391.
177. Dutly F, Altwegg M. Whipple's disease and 'Tropheryma whippelii'. Clin. Microbiol. Rev. 2001; 14; 561-583.
178. Marth T, Raoult D. Whipple's disease. Lancet 2003; 361; 239-246.
179. Bai JC, Mazure RM, Vazquez H et al. Whipple's disease. Clin. Gastroenterol. Hepatol. 2004; 2; 849-860.
180. Muir-Padilla J, Myers JB. Whipple disease: a case report and review of the literature. Arch. Pathol. Lab. Med. 2005; 129; 933-936.
181. Monkemuller K, Fry LC, Rickes S, Malfertheiner P. Whipple's disease. Curr. Infect. Dis. Report 2006; 8; 96-102.
182. Raoult D, Birg ML, La Scola B et al. Cultivation of the bacillus of Whipple's disease. N. Engl. J. Med. 2000; 342; 620-625.
183. Misbah SA, Mapstone NP. Whipple's disease revisited. J. Clin. Pathol. 2000; 53; 750-755.
184. Misbah SA, Aslam A, Costello C. Whipple's disease. Lancet 2004; 363; 654-656.
185. Bassotti G, Pelli MA, Ribacchi R. et al. Giardia lamblia infestation reveals underlying Whipple's disease in a patient with longstanding constipation. Am. J. Gastroenterol. 1991; 86; 371-374.
186. Gil Ruiz JA, Gil Simon P, Aparicio Duque R, Mayor Jerez JL. Association between Whipple's disease and Giardia lamblia infection. Rev. Esp. Enferm. Dig. 2005; 97; 521-526.
187. Desnues B, Ihrig M, Raoult D, Mege J-L. Whipple's disease: a macrophage disease. Clin. Vaccine Immunol. 2006; 13; 170-178.
188. Kuhajda FP, Belitsos NJ, Keren DF, Hutchins GM. A submucosal variant of Whipple's disease. Gastroenterology 1982; 82; 46-50.
189. Gillin JS, Urmacher C, West R, Shike M. Disseminated Mycobacterium avium-intercellulare infection in acquired immunodeficiency syndrome mimicking Whipple's disease. Gastroenterology 1983; 85; 1187-1191.
190. McCullough K, Damjanov I. Intestinal histoplasmosis mimicking Whipple's disease. Histopathology 2006; 48; 306-323.
191. Wolfe MS. Giardiasis. Clin. Microbiol. Rev. 1992; 5; 93-100.
192. Phillips SC, Mildvan D, William DC, Gelb AM, White MC. Sexual transmission of enteric protozoa and helminths in a venereal-disease-clinic population. N. Engl. J. Med. 1981; 305; 603-606.
193. da Silva JR, Coutinho SG, Dias LB, de Figueiredo N. Histopathologic findings in giardiasis: a biopsy study. Am. J. Dig. Dis. 1964; 10; 355-365.
194. Sun T. The diagnosis of giardiasis. Am. J. Surg. Pathol. 1980; 4; 265-271.
195. Oberhuber G, Kastner N, Stolte M. Giardiasis: a histologic analysis of 567 cases. Scand. J. Gastroenterol. 1997; 32; 48-51.
196. Levinson JD, Nastro LJ. Giardiasis with total villous atrophy. Gastroenterology 1978; 74; 271-275.
197. Current WL, Reese NC, Ernst JV, Bailey WS, Heyman MB, Weinstein WM. Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission. N. Engl. J. Med. 1983; 308; 1252-1257.
198. Meisel JL, Perera DR, Meligro C, Rubin CE. Overwhelming watery diarrhea associated with Cryptosporidium in an immunocompromised patient. Gastroenterology 1978; 70; 1156-1160.
199. MacKenzie WR, Hoxie NJ, Proctor ME et al. A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N. Engl. J. Med. 1994; 331; 161-167.
200. Chappell CL, Okhuysen PC. Cryptosporidiosis. Curr. Opin. Infect. Dis. 2002; 15; 523-527.
201. Hunter PR, Thompson RCA. The zoonotic transmission of Giardia and Cryptosporidium. Int. J. Parasitol. 2005; 35; 1181-1190.
202. Jessurun J, Pambuccian S. Infectious and inflammatory disorders of the gallbladder and extrahepatic biliary tract. In Odze RD, Goldblum JR, Crawford JM eds. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. Philidelphia: Saunders 2004; 609-638.
203. Keeling PJ, Fast NM. Microsporidia: biology and evolution of highly reduced intracellular parasites. Annu. Rev. Microbiol. 2002; 56; 93-116.
204. Orenstein JM, Chiang J, Steinberg W, Smith PD, Rotterdam H, Kotler DP. Intestinal microsporidiosis as a cause of diarrhea in human immunodeficiency virus-infected patients. Hum. Pathol. 1990; 21; 475-481.
205. Asmuth DM, DeGirolami PC, Federman M et al. Clinical features of microsporidiosis in patients with AIDS. Clin. Infect. Dis. 1994; 18; 819-825.
206. van Gool T, Hollister WS, Schattenkerk JE et al. Diagnosis of Enterocytozoon bieneusi microsporidiosis in AIDS patients by recovery of spores from faeces. Lancet 1990; 336; 697-698.
207. Orenstein JM, Zierdt W, Zierdt C, Kotler DP. Identification of spores of Enteroctyozoon bieneusi in stool and duodenal fluid from AIDS patients. Lancet 1990; 336; 1127-1128.
208. Rabeneck L, Gyorkey F, Genta RM, Gyorkey P, Foote LW, Risser JM. The role of microsporidia in the pathogenesis of HIV-related chronic diarrhea. Ann. Intern. Med. 1993; 119; 895-899.
209. van Gool T, Canning EU, Gillis H, van den Bergh-Weerman MA, Eeftinck-Schattenkerk JK, Dankert J. Septata intestinalis frequently isolated from stool of AIDS patients with a new cultivation method. Parasitology 1994; 109; 281-289.
210. Franzen C, Muller A. Microsporidiosis: human diseases and diagnosis. Microbes Infect. 2001; 3; 389-400.
211. Weber R, Bryan RT, Owen RL, Wilcox CM, Gorelkin L, Visvesvara GS. Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates. The Enteric Opportunistic Infections Working Group. N. Engl. J. Med. 1992; 326; 161-166.
212. Giang TT, Kotler DP, Garro ML, Orenstein JM. Tissue diagnosis of intestinal microsporidiosis using the chromotrope-2R modified trichrome stain. Arch. Pathol. Lab. Med. 1993; 117; 1249-1251.
213. Sobottka I, Schwartz DA, Schottelius J et al. Prevalence and clinical significance of intestinal microsporidiosis in human immunodeficiency virus-infected patients with and without diarrhea in Germany: a prospective coprodiagnostic study. Clin. Infect. Dis. 1998; 26; 475-480.
214. Orenstein JM. Diagnostic pathology of microsporidiosis. Ultrastruct. Pathol. 2003; 27; 141-149.
215. Conteas CN, Berlin OG, Ash LR, Pruthi JS. Therapy for human gastrointestinal microsporidiosis. Am. J. Trop. Med. Hyg. 2000; 63; 121-127.